Lorazepam (Ativan)

About this episode

The episode discusses the uses and evidence surrounding the benzodiazepine Lorazepam, particularly in relation to catatonia.

Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up? References: https://www.ncbi.nlm.nih.gov/books/NBK532890/ https://pubmed.ncbi.nlm.nih.gov/36805317/ https://pubmed.ncbi.nlm.nih.gov/6120058/ https://pubmed.ncbi.nlm.nih.gov/10229064/ https://psychopharmacologyinstitute.com/section/catatonia-diagnosis-the-lorazepam-challenge-2911-5899/

People in this episode

Hosts: Dr. Tanner Hewitt, Dr. Larry Wang, Dr. Bradley Miller

Topics covered

• benzodiazepine
• psychiatry
• catatonia
• medication efficacy
• mental health

Keywords

• Lorazepam
• Ativan
• benzodiazepine
• catatonia
• psychiatry
• medication
• mental health

Mentioned in this episode

Organizations: NCBI, PubMed, Psychopharmacology Institute

Products: Lorazepam, Ativan

More episodes of PsychRounds: The Psychiatry Podcast

• Modafinil (Provigil) · June 3, 2026 · 20 min
• Naltrexone · May 20, 2026 · 16 min
• Placebo Effect and Response in Psychiatry · May 6, 2026 · 22 min
• Amantadine (Symmetrel) · April 8, 2026 · 17 min
• VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) · March 21, 2026 · 17 min
• A DSM Conversation with Dr. Allen Frances · February 25, 2026 · 56 min